Starling Oncology
STLN
6.43
-0.15
-2.28%
Starling Oncology
US · STLN
#3565 by market cap
6.43
-0.15
-2.28%
Live - 5344 symbols - heartbeat 114s ago
· 2026-10-08 09:13
Pre-market
6.41
-0.31%
After-hours
6.43
0.00%
- Market cap
- 655.32M
- P/E (TTM)i
- -22.17
- P/Bi
- -26.35
- EPSi
- -0.54
- Div yieldi
- 0.00%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on STLN?
Anonymous reader poll. Unscientific, not investment advice.
About Starling Oncology
The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
- Founded
- 2007
- CEO
- Mr. Daniel Virnich
- Employees
- 641
- Headquarters
- Cerritos, California, United States of America
- Fiscal year end
- 12-31
- Website
- theoncologyinstitute.com
Company profile
- Exchange
- US
- Symbol
- STLN
- Market-cap rank
- #3565
- Market cap
- 655.32M
- Float cap
- 571.55M
- Shares out
- 101.92M
- Float shares
- 88.89M
Sectors & themes
Quote time 2026-10-08 09:13:48 · For reference only, not investment advice and not tailored to your situation.